Research study Program year 2023 Source: CMS Open Payments

iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study

Research payments

$57,850

16 payments

Through program year 2023, $57,850 in research payments was reported against iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study, across 16 payments, paid by Glaukos Corporation.

Paid by: Glaukos Corporation
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2023	Research	$57,850	16

Breakdown

Who paid Research payments · program year 2023

Glaukos Corporation $57,850 16 payments

Who received the money Research payments · program year 2023

MIGS Consulting, LLC Organisation paid for research $48,020 12 payments
InComm Digital Solutions, LLC Organisation paid for research $9,830 4 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

1 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

Steven Sarkisian Oklahoma City, OK Named on 16 payments

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.